The Ellison Institute of Technology is set to establish one of Europe’s largest private life sciences and technology R&D campuses at Oxford Science Park. The initiative will expand the institute into a 2 million square foot innovation hub, significantly larger than the initially planned 300,000 square feet, and will accommodate up to 7,000 scientists, technologists, and entrepreneurs. The campus is designed to address pressing global challenges in health, artificial intelligence, and climate research, forming a central part of the UK’s post-pandemic strategy for scientific and commercial growth.

The new campus will be designed by renowned architect Norman Foster, with construction scheduled to begin in 2026. The expansion reflects Larry Ellison’s vision of creating a world-leading hub for research and innovation, focused on solutions for food security, global health, and environmental sustainability.

The institute has cultivated close ties with former Prime Minister Sir Tony Blair and senior Whitehall leaders, aiming to support a wave of spin-off companies and enhance Oxford’s position as a global innovation centre. The project is also expected to generate significant economic benefits, including thousands of jobs and billions in spin-offs and start-ups.

Following recent leadership changes, the institute is emphasising a renewed commercial focus to stabilise operations and advance its ambitious agenda. The Oxford campus has established strong partnerships with university leadership, including Vice-Chancellor Irene Tracey, who highlights the campus as a key factor in attracting top research talent and investment.

The Ellison campus will feature extensive laboratory space, an oncology clinic, an innovation auditorium, a library, and specialised facilities for AI-driven vaccine research in collaboration with Oxford’s Vaccine Group. The expansion represents a transformative effort in applied science, combining cutting-edge technology, health initiatives, and Oxford’s longstanding academic excellence.

Larry Ellison’s £890 million commitment positions Oxford as a major hub for global life sciences and technological innovation, promising lasting scientific, entrepreneurial, and economic impact for the UK and the wider international community.